Article
NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jan 2000
Nebert Daniel W, Roe Amy L, Vandale Susan E, Bingham Eula, Oakley Gregory G
Abstract excerpt
NAD(P)H:quinone oxidoreductase (NQO1) catalyzes the two- or four-electron reduction of numerous endogenous and environmental quinones (e.g., the vitamin E alpha-tocopherol quinone, menadione, benzene quinones). In laboratory animals treated with various environmental chemicals, inhibition of NQO1 metabolism has long been known to increase the risk of toxicity or cancer. Currently, there are 22 reported...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
